Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protein and energy interactions in critically ill children
NL-OMON32972Withdrawn
- Sponsor
- Erasmus MC
- Start
- Apr 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of human insulin in hyperglycemia, insulin resistance (IR) and sepsis (2 arms), sponsored by Erasmus MC. Primary endpoints: Whole body protein balance in children and Whole body protein balance in neonates. Planned start Apr 2009; status: withdrawn.
02
Drugs
human insulin
03
Conditions
hyperglycemiainsulin resistance (IR)sepsis
Beyond the preview
Go deeper on NL-OMON32972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32972.